Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
ContraFect (CFRXQ)
OTHER OTC:CFRXQ
Holding CFRXQ?
Track your performance easily
CFRXQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.04
Previous Close$0.01
Volume1.05K
Average Volume (3M)N/A
Market Cap
$11.00
Enterprise Value-$2.86M
Total Cash (Recent Filing)$5.41M
Total Debt (Recent Filing)$2.55M
Price to Earnings (P/E)0.0
Beta7.77
Next Earnings
Aug 09, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-19.27
Shares Outstanding10,704,803
10 Day Avg. Volume157
30 Day Avg. VolumeN/A
Standard Deviation12.80
R-Squared0.00068
Alpha1.45
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.09
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ownership Overview
―
Insiders
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
CFRXQ FAQ
What was ContraFect’s price range in the past 12 months?
ContraFect lowest stock price was <$0.01 and its highest was $0.04 in the past 12 months.
What is ContraFect’s market cap?
Currently, no data Available
When is ContraFect’s upcoming earnings report date?
ContraFect’s upcoming earnings report date is Aug 09, 2024 which is 136 days ago.
How were ContraFect’s earnings last quarter?
Currently, no data Available
Is ContraFect overvalued?
According to Wall Street analysts ContraFect’s price is currently Overvalued.
Does ContraFect pay dividends?
ContraFect does not currently pay dividends.
What is ContraFect’s EPS estimate?
ContraFect’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does ContraFect have?
ContraFect has 10,704,803 shares outstanding.
What happened to ContraFect’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of ContraFect?
Among the largest hedge funds holding ContraFect’s share is Moore Capital Management LP. It holds ContraFect’s shares valued at N/A.
---
ContraFect Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
ContraFect
ContraFect Corp. is a clinical stage biotechnology company , which engages in discovering and developing therapeutic protein and antibody products for the treatment of life-threatening infectious diseases. Its pipeline consists of CF-301, a bacteriophage-derived lysin with potent activity against Staphylococcus aureus bloodstream infections; and CF-404, which composed of three fully human monoclonal antibodies designed to treat all seasonal strains of human influenza. The company was founded by Robert Nowinski on March 5, 2008 and is headquartered in Yonkers, NY.
---
---